PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells

Lars Petersen; Lars Ringgaard; Fredrik Melander; Ragnhild Garborg Østrem; Kasper Kristensen; Jonas  Henriksen; Dennis  Elema; Andreas  Kjær; Thomas  Andresen

PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells

Lars Petersen, Lars Ringgaard, Fredrik Melander, Ragnhild Garborg Østrem, Kasper Kristensen, Jonas Henriksen, Dennis Elema, Andreas Kjær, Thomas Andresen

Department of Health Technology

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	P656
Journal	Journal for ImmunoTherapy of Cancer
Volume	7
Issue number	Suppl. 1
ISSN	2051-1426
Publication status	Published - 2019
Event	34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) - Gaylord National Hotel & Convention Center, National Harbour, United States Duration: 6 Nov 2019 → 10 Nov 2019 https://www.sitcancer.org/2019/home

Conference

Conference	34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
Location	Gaylord National Hotel & Convention Center
Country/Territory	United States
City	National Harbour
Period	06/11/2019 → 10/11/2019
Internet address	https://www.sitcancer.org/2019/home

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

OpenUrl availability

Full text

Cite this

@article{35da08cf116b4fe98b5b50fc70f07ddb,

title = "PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells",

author = "Lars Petersen and Lars Ringgaard and Fredrik Melander and {\O}strem, \{Ragnhild Garborg\} and Kasper Kristensen and Jonas Henriksen and Dennis Elema and Andreas Kj{\ae}r and Thomas Andresen",

year = "2019",

language = "English",

volume = "7",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BioMed Central Ltd.",

number = "Suppl. 1",

note = "34th Annual Meeting \& Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019), SITC2019 ; Conference date: 06-11-2019 Through 10-11-2019",

url = "https://www.sitcancer.org/2019/home",

}

PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells. / Petersen, Lars; Ringgaard, Lars; Melander, Fredrik et al.
In: Journal for ImmunoTherapy of Cancer, Vol. 7, No. Suppl. 1, P656, 2019.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells

AU - Petersen, Lars

AU - Ringgaard, Lars

AU - Melander, Fredrik

AU - Østrem, Ragnhild Garborg

AU - Kristensen, Kasper

AU - Henriksen, Jonas

AU - Elema, Dennis

AU - Kjær, Andreas

AU - Andresen, Thomas

PY - 2019

Y1 - 2019

M3 - Conference abstract in journal

SN - 2051-1426

VL - 7

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

IS - Suppl. 1

M1 - P656

T2 - 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)

Y2 - 6 November 2019 through 10 November 2019

ER -